New cochlear implant aims to help those with partial hearing hear better

NCT ID NCT04741009

Completed Disease control Sponsor: Cochlear Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a new cochlear implant (CI632) in 10 adults who have some low-frequency hearing but poor high-frequency hearing. The goal was to see if the implant improves speech understanding and overall hearing. Participants received the implant and were followed to measure hearing performance.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: CI632 cochlear implant with Slim Modiolar Electrode
What this could lead to: If successful, this implant could help adults with low-frequency hearing loss hear speech more clearly, expanding who can benefit from cochlear implants.
What could go wrong: This is a small, early feasibility study with only 10 participants, so results may not apply to everyone. The implant is a device, not a cure, and hearing may still require ongoing management.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LOW-FREQUENCY RESIDUAL HEARING are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Hearing Loss, Sensorineural sensorineural hearing loss disorder X-linked mixed hearing loss with perilymphatic gusher

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

LOW-FREQUENCY RESIDUAL HEARING SENSORINEURAL HEARING LOSS

Contacts and locations

Locations

Cleveland Clinic

Cleveland, Ohio, 44106, United States
Midwest Ear Institute

Kansas City, Missouri, 64111, United States
UMass Memorial Medical Center

Worcester, Massachusetts, 01655, United States
University Hospitals

Cleveland, Ohio, 44106, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.